华润三九益气清肺颗粒首次纳入国家医保目录

Core Viewpoint - China Resources Sanjiu announced that its drug Yiqi Qingfei Granules has been included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025) through negotiation, with the agreement effective from January 1, 2026, to December 31, 2027 [1] Group 1 - The drug Yiqi Qingfei Granules received its drug registration certificate from the National Medical Products Administration in January 2025, officially approved for market launch [1] - The indications for Yiqi Qingfei Granules include nourishing Qi and Yin, strengthening the spleen, clearing heat and dampness, and are suitable for short-term symptoms after infectious diseases, characterized by Qi and Yin deficiency, spleen deficiency, and residual pathogenic factors [1] - Symptoms treated by the drug include fatigue, shortness of breath after activity, dry cough with little phlegm, throat discomfort, gastric distension, poor appetite, and loose stools, with a pale or red tongue and thin, rapid pulse [1]